Understanding the Path From Research to FDA Approval: What It Takes to Bring a Type 1 Diabetes Treatment to Patients

Before any new Type 1 diabetes treatment reaches patients, it must pass through years of research and rigorous testing. Here's how the drug development and approval process actually works.

Community video — lay discussion, not peer-reviewed research

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

cureresearchclinical trial

Key takeaways

New treatments go through a preclinical stage involving simulations and animal testing before ever being tested in humans
Clinical trials have three distinct phases, each designed to answer different questions about safety and effectiveness
Phase 1 trials focus on safety with a small number of participants; Phase 2 expands to a few hundred people to test how well the drug works
Phase 3 is the largest and most critical step, involving hundreds or thousands of people to confirm both efficacy and safety before FDA review

The Long Journey Before Human Testing Begins

Before any new treatment is tested in people, researchers spend years in what's called the preclinical stage. During this phase, potential therapies are tested using computer simulations and in animal models. This foundational work helps researchers understand how a treatment might work and whether it's safe enough to move forward with human testing.

Phase 1: Testing for Safety in a Small Group

Once preclinical work is complete, clinical trials—testing in humans—can begin. Phase 1 trials are the first step. These studies involve only a small number of participants, ranging from just a few people to around 100. The primary goal is safety: researchers watch carefully for any unexpected or undesired side effects. Phase 1 also provides an initial look at how well the treatment works and helps researchers determine what the optimal dose might be for the next phase of testing.

Phase 2: Expanding the Study to Test Effectiveness

Phase 2 trials involve a larger group, typically up to a couple hundred participants. At this stage, the focus shifts to efficacy—does the treatment actually do what researchers hope it will do? This phase builds on the safety information from Phase 1 while providing a clearer picture of whether the treatment is working as intended.

Phase 3: The Critical Test in a Large Population

Phase 3 is the most important stage of clinical trial testing. These studies involve hundreds or even thousands of participants and examine both the efficacy and safety of the treatment across a much larger, more diverse population. The data generated in Phase 3 is what ultimately gets submitted to the FDA for review and approval. This phase determines whether a treatment is ready to become available to patients.

From Approval to Patient Access

After Phase 3 is complete, researchers compile all the data and submit it to the FDA for consideration. The full timeline from preclinical research through FDA approval typically spans many years. Understanding this process helps explain why promising treatments—even those showing real potential—take time to reach patients who need them.

Evidence label

Source: YouTube community video. Evidence type: Community video — lay discussion, not peer-reviewed research. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.